专利检索 ap:("Jiro Sawada" OR "Sadafumi Omura" OR "Michinori Shibata" OR "Sadao Machida") AND inv:"Sadao Machida" 第 1 页

1.

发明授权
Antibiotic TM-481 derived from microorganism of the streptomyces ribosidificus group 失效
标题翻译：抗生素TM-481衍生自{i streptomyces ribosidificus {l group

公开(公告)号：US3950514A

公开(公告)日：1976-04-13

申请号：US503165

申请日：1974-09-04

申请人： Jiro Sawada , Sadafumi Omura , Michinori Shibata , Sadao Machida

发明人： Jiro Sawada , Sadafumi Omura , Michinori Shibata , Sadao Machida

IPC分类号： A61K35/74 , C07G11/00 , C12P1/06 , A61K35/00

CPC分类号： A61K36/06 , C07G11/00 , Y10S435/886

摘要： A new polyether group antibiotic, TM-481, having the estimated empirical formula C.sub.42-45 H.sub.71-75 O.sub.14-15 Na and possessing an antibacterial activity against pathogenic microorganisms, particularly Gram-positive bacteria is obtained by culturing a TM-481 producing microorganism of the Streptomyces ribosidificus group in a nutrient medium therefor.

摘要翻译： 通过培养产生TM-481的链霉菌的微生物获得具有估计经验式C42-45H71-75O14-15Na并且具有抗病原微生物，特别是革兰氏阳性菌的抗菌活性的新型聚醚组抗生素TM-481 核糖体组在营养培养基中。